Cyclopharm Limited (ASX:CYC)

Cyclopharm Balance Sheet

Financials in millions AUD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	20.57	11.73	20.3	29.25	1.87
Cash & Short-Term Investments	20.57	11.73	20.3	29.25	1.87
Cash Growth	75.40%	-42.22%	-30.61%	1460.55%	-85.20%
Accounts Receivable	4.91	5.74	5.25	4.66	5.35
Other Receivables	1.52	0.92	2.46	3.44	3.72
Receivables	6.43	6.67	7.71	8.1	9.07
Inventory	13.25	10.12	8.29	5.51	4.74
Other Current Assets	2.14	1.68	0.57	0.39	0.3
Total Current Assets	42.39	30.2	36.87	43.25	15.98
Property, Plant & Equipment	13.1	9.19	6.6	6.25	5.81
Goodwill	0.93	0.9	0.87	0.87	0.87
Other Intangible Assets	4.18	4.04	3.78	3.77	3.64
Long-Term Deferred Tax Assets	0.75	0.76	0.64	0.82	1.19
Long-Term Deferred Charges	0.79	0.79	0.79	0.79	0.79
Other Long-Term Assets	-	0.03	-	-	-
Total Assets	62.13	45.91	49.54	55.74	28.28
Accounts Payable	3.8	3.15	4.4	2.17	3.3
Accrued Expenses	2.76	1.48	1.13	1.23	1.02
Current Portion of Leases	0.63	0.21	0.21	0.18	0.15
Current Income Taxes Payable	-	0.04	0.09	0.1	0.11
Other Current Liabilities	3.43	3.79	2.1	3.73	1.1
Total Current Liabilities	10.61	8.67	7.94	7.42	5.68
Long-Term Leases	7.66	4.01	4.12	4.33	4.56
Long-Term Unearned Revenue	0.9	0.9	0.9	0.9	0.89
Other Long-Term Liabilities	0.22	0.07	0.05	0.03	0.02
Total Liabilities	19.4	13.65	13.01	12.67	11.16
Common Stock	92.41	69.11	68.75	68.31	36.97
Retained Earnings	-47.86	-34.66	-29.07	-21.58	-15.66
Comprehensive Income & Other	-1.82	-2.2	-3.14	-3.66	-4.19
Shareholders' Equity	42.73	32.26	36.54	43.07	17.12
Total Liabilities & Equity	62.13	45.91	49.54	55.74	28.28
Total Debt	8.29	4.23	4.33	4.51	4.71
Net Cash (Debt)	12.28	7.5	15.96	24.74	-2.83
Net Cash Growth	63.78%	-53.03%	-35.47%	-	-
Net Cash Per Share	0.12	0.08	0.17	0.28	-0.04
Filing Date Shares Outstanding	111.14	94.1	93.05	93.37	93.37
Total Common Shares Outstanding	111.14	94.1	93.05	93.37	80.27
Working Capital	31.77	21.53	28.93	35.83	10.29
Book Value Per Share	0.38	0.34	0.39	0.46	0.21
Tangible Book Value	37.62	27.31	31.89	38.43	12.61
Tangible Book Value Per Share	0.34	0.29	0.34	0.41	0.16
Land	2.41	2.45	0.5	0.55	0.51
Machinery	10.67	8.99	4.85	4.65	4.3
Construction In Progress	0.02	-	0.1	0.1	0.09
Leasehold Improvements	5.87	5.68	3.25	2.72	2.26

Source: S&P Global Market Intelligence. Standard template. Financial Sources.